BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32798842)

  • 1. An SBM-based machine learning model for identifying mild cognitive impairment in patients with Parkinson's disease.
    Zhang J; Li Y; Gao Y; Hu J; Huang B; Rong S; Chen J; Zhang Y; Wang L; Feng S; Wang L; Nie K
    J Neurol Sci; 2020 Nov; 418():117077. PubMed ID: 32798842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Parkinson's disease with mild cognitive impairment by using combined MR imaging and electroencephalogram.
    Zhang J; Gao Y; He X; Feng S; Hu J; Zhang Q; Zhao J; Huang Z; Wang L; Ma G; Zhang Y; Nie K; Wang L
    Eur Radiol; 2021 Oct; 31(10):7386-7394. PubMed ID: 33389038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning trained with quantitative susceptibility mapping to detect mild cognitive impairment in Parkinson's disease.
    Shibata H; Uchida Y; Inui S; Kan H; Sakurai K; Oishi N; Ueki Y; Oishi K; Matsukawa N
    Parkinsonism Relat Disord; 2022 Jan; 94():104-110. PubMed ID: 34906915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait-Based Machine Learning for Classifying Patients with Different Types of Mild Cognitive Impairment.
    Chen PH; Lien CW; Wu WC; Lee LS; Shaw JS
    J Med Syst; 2020 Apr; 44(6):107. PubMed ID: 32328889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of mild cognitive impairment in Parkinson's disease using gradient boosting decision tree models based on multilevel DTI indices.
    Chen B; Xu M; Yu H; He J; Li Y; Song D; Fan GG
    J Transl Med; 2023 May; 21(1):310. PubMed ID: 37158918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating cognitive status in Parkinson's disease through functional connectomics and machine learning.
    Abós A; Baggio HC; Segura B; García-Díaz AI; Compta Y; Martí MJ; Valldeoriola F; Junqué C
    Sci Rep; 2017 Mar; 7():45347. PubMed ID: 28349948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum level of YWHAG as a diagnostic marker of cognitive impairment in Parkinson's disease patients.
    Peng Y; Zhu L; Bai Q; Wang L; Li Q
    Acta Neurol Belg; 2024 Jun; 124(3):879-885. PubMed ID: 38286872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
    Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
    J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Gait Pattern for Detecting Mild Cognitive Impairment in Parkinson's Disease.
    Russo M; Amboni M; Barone P; Pellecchia MT; Romano M; Ricciardi C; Amato F
    Sensors (Basel); 2023 Feb; 23(4):. PubMed ID: 36850582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural connectivity from DTI to predict mild cognitive impairment in de novo Parkinson's disease.
    Huang X; He Q; Ruan X; Li Y; Kuang Z; Wang M; Guo R; Bu S; Wang Z; Yu S; Chen A; Wei X
    Neuroimage Clin; 2024; 41():103548. PubMed ID: 38061176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
    Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
    J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted Resting-state Functional Connectivity of the Nucleus Basalis of Meynert in Parkinson's Disease with Mild Cognitive Impairment.
    Zhang C; Wu C; Zhang H; Dou W; Li W; Sami MU; Xu K
    Neuroscience; 2020 Aug; 442():228-236. PubMed ID: 32659339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A support vector machine-based method to identify mild cognitive impairment with multi-level characteristics of magnetic resonance imaging.
    Long Z; Jing B; Yan H; Dong J; Liu H; Mo X; Han Y; Li H
    Neuroscience; 2016 Sep; 331():169-76. PubMed ID: 27343830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.
    Choi H; Kim YK; Yoon EJ; Lee JY; Lee DS;
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):403-412. PubMed ID: 31768599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of machine learning method on automatic classification of motor subtype of Parkinson's disease based on multilevel indices of rs-fMRI.
    Pang H; Yu Z; Yu H; Cao J; Li Y; Guo M; Cao C; Fan G
    Parkinsonism Relat Disord; 2021 Sep; 90():65-72. PubMed ID: 34399160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease.
    Chaturvedi M; Bogaarts JG; Kozak Cozac VV; Hatz F; Gschwandtner U; Meyer A; Fuhr P; Roth V
    Clin Neurophysiol; 2019 Oct; 130(10):1937-1944. PubMed ID: 31445388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.
    Fengler S; Kessler J; Timmermann L; Zapf A; Elben S; Wojtecki L; Tucha O; Kalbe E
    PLoS One; 2016; 11(7):e0159318. PubMed ID: 27437705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.